Shares of Palo Alto Networks ( PANW ) rose around 2% to $265.73 in the afternoon trading on Wednesday, on track to end a six-session losing streak. The stock has fallen around 12.34% between June 2 and June 9, compared to a 2.94% decline in the S&P 500 over the same period. Shares have declined despite Palo Alto Networks reporting quarterly earnings and revenue above expectations, raising its outl...
Shares of Palo Alto Networks ( PANW ) rose around 2% to $265.73 in the afternoon trading on Wednesday, on track to end a six-session losing streak. The stock has fallen around 12.34% between June 2 and June 9, compared to a 2.94% decline in the S&P 500 over the same period. Shares have declined despite Palo Alto Networks reporting quarterly earnings and revenue above expectations, raising its outlook, issuing stronger-than-expected guidance, and outlining longer-term profitability targets. The company also reported strong year-on-year growth across its business segments, while analysts remained broadly positive following the results. According to Seeking Alpha’s Quant rating system, PANW is rated a Hold with a score of 3.43 out of 5, with an A in terms of profitability but a D- in terms of valuation. While a recent analysis said Palo Alto Networks remains well positioned for long-term growth, supported by strong organic expansion in its next-generation security business, growing demand for its AI-related products, and an increase in contracted future revenue. The note argued that the stock's valuation does not fully reflect the company's long-term targets, adding that "buying at today’s prices means buying the 2030 ARR at 12x," and noting that "as long as the new organic flow holds up as it is doing, the plan practically sustains itself." On Wall Street, analysts are bullish , with 44 out of 55 analysts rating the stock with a buy or higher, 10 suggesting to hold, and one of them recommending a sell or lower. Shares have gained around 28% over the past month and remain up around 42.5% year to date. More on Palo Alto Networks Palo Alto Networks: The Market Is Pricing 2030 At 12x Palo Alto Networks: Q4 Organic Revenue Growth Decelerates; M&A Optimism Is Already Priced In (Rating Downgrade) Palo Alto Networks: Strong AI Security Story, But The Stock Has Run Too Far What’s next for Palo Alto Networks after its Q3 earnings beat and guidance raise? Earnings Scoreboard: 10...
With Sleep Studio the Echo Glow can light up to let kids know when they should be sleeping or can get out of bed. | Image: Amazon Amazon has launched a new feature for its Echo and Echo Kids smart speakers called Sleep Studio that's designed to make the daily transition to bedtime more enticing for kids and less stressful for parents and caregivers. The feature uses a combination of bedtime storie...
With Sleep Studio the Echo Glow can light up to let kids know when they should be sleeping or can get out of bed. | Image: Amazon Amazon has launched a new feature for its Echo and Echo Kids smart speakers called Sleep Studio that's designed to make the daily transition to bedtime more enticing for kids and less stressful for parents and caregivers. The feature uses a combination of bedtime stories, relaxing sounds, and guided meditations along with scheduling and customization options accessible only to adults. Sleep Studio is now available to those with a $5.99 per month Amazon Kids Plus subscription at no extra cost. Amazon offers a free one month trial of the service, but purchasing an Echo Kids device will also get you a complementary six or 12-month subscription … Read the full story at The Verge.
We're selling 75 shares of Procter & Gamble at roughly $150 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will own 375 shares of PG, reducing its weight in the portfolio to roughly 1.5% from 1.75%. We're making another sale on Wednesday to increase our cash pile and protect against future market volatility. One of our main concerns expressed by Jim in his Sunday column is the fl...
We're selling 75 shares of Procter & Gamble at roughly $150 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will own 375 shares of PG, reducing its weight in the portfolio to roughly 1.5% from 1.75%. We're making another sale on Wednesday to increase our cash pile and protect against future market volatility. One of our main concerns expressed by Jim in his Sunday column is the flood of new supply that the market must absorb, and President Donald Trump said U.S. attacks on Iran are expected to resume later Wednesday in response to the downing of a U.S. helicopter. Similar to our scaling back earlier in the session of Cardinal Health , we want to capitalize on this market rotation into defensive groups by selling some shares of Procter & Gamble, the consumer products powerhouse behind everyday brands like Tide. Our P & G investment thesis is that it would act like a hedge in the portfolio when the market gets more worried about the AI buildout and tech valuations. True to form, P & G is up about 4% in June compared to the broader tech sector's 7% decline. PG .GSPT mountain 2026-05-31 P & G vs. Information Technology sector index in June Given the move, we're downgrading P & G back to our hold-equivalent 2 rating . We'll get more positive on P & G if the stock gives back its recent gains or we see more evidence that the company can accelerate its growth rate. Expectations call for approximately 2.5% growth in organic sales and adjusted earnings-per-share (EPS) in fiscal 2027, according to FactSet. We're realizing a 2% gain on P & G stock bought in November 2025. (Jim Cramer's Charitable Trust is long PG, CAH. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after iss...
MicroStockHub/iStock via Getty Images Asset class: U.S. Equity Objective: Seeks long-term capital appreciation Morningstar category: Small Growth Class A: NWGPX Class R6: NWKEX Inst Svc: NWGSX Executive summary The Fund returned -8.12% (IS Share Class)( NWGSX ) during Q1 2026 vs. -2.81% for the Russell 2000® Growth Index. Stock selection within the healthcare, information technology, and consumer ...
MicroStockHub/iStock via Getty Images Asset class: U.S. Equity Objective: Seeks long-term capital appreciation Morningstar category: Small Growth Class A: NWGPX Class R6: NWKEX Inst Svc: NWGSX Executive summary The Fund returned -8.12% (IS Share Class)( NWGSX ) during Q1 2026 vs. -2.81% for the Russell 2000® Growth Index. Stock selection within the healthcare, information technology, and consumer staples sectors detracted from the Fund's relative performance. While we have many economically sensitive holdings, the portfolio as a whole is best described as "all weather". We continue to focus our efforts on under-appreciated high quality growth companies. We continue to find investment opportunities across various sectors where valuations are attractive, and earnings growth is expected to exceed the growth of the market as a whole. Portfolio management Renaissance Investment Management Paul A. Radomski, CFA Portfolio Manager Fund tenure since 2017 Market Environment The more cyclical sectors of the Russell 2000® Growth Index were the best performing which included energy, materials, and industrials. Traditional growth sectors of the small cap market performed poorly. Information technology, notably software, was the worst performing sector. Health care also underperformed due to weakness in health care technology and equipment & services. This environment hindered our performance as we are typically overweight the growth sectors and underweight the more cyclical ones. In fact, we had no exposure during the quarter to energy or materials. Although we were overweight industrials, it is typically companies that are less cyclical than average. Performance Review Our growth, quality and momentum factors all underperformed the benchmark. Our earnings per share (EPS) growth and revenue growth internally measured factors underperformed which are factors we typically favor. Effective 2/20/26, the Nationwide WCM Focused Small Cap Fund underwent a subadviser change and is now ma...
Terroa Frasers Group ( SDIPF ) has offered to buy Hugo Boss ( BOSSY ) for €38 per share in cash. Frasers plans to enter into an acquisition facility agreement with BNP Paribas, Deutsche Bank Luxembourg S.A., National Westminster Bank plc and Standard Chartered Bank as lenders, among others, according to a statement on Wednesday. Frasers holds 18.3 million Hugo Boss ( BOSSY ) shares. The Frasers of...
Terroa Frasers Group ( SDIPF ) has offered to buy Hugo Boss ( BOSSY ) for €38 per share in cash. Frasers plans to enter into an acquisition facility agreement with BNP Paribas, Deutsche Bank Luxembourg S.A., National Westminster Bank plc and Standard Chartered Bank as lenders, among others, according to a statement on Wednesday. Frasers holds 18.3 million Hugo Boss ( BOSSY ) shares. The Frasers offer won't be subject to a minimum acceptance threshold, according to the statement. Frasers expects to complete its offer in the second half of 2026. The takeover bid represents a 4..2% premium to Hugo Boss's closing price on Wednesday. Hugo Boss ( BOSSY ) ADRs rose 8% on Wednesday. More on Hugo Boss, Frasers Group Plc Hugo Boss AG 2026 Q1 - Results - Earnings Call Presentation Hugo Boss AG (BOSSY) Q1 2026 Earnings Call Transcript Hugo Boss: Too Early To Turn Bullish Yet Seeking Alpha’s Quant Rating on Hugo Boss Historical earnings data for Hugo Boss
For the first time, the American College of Obstetricians & Gynecologists (ACOG) has released its own recommendations for maternal vaccination , providing formal guidance that diverges from that of the Centers for Disease Control and Prevention amid unprecedented policy changes and meddling from anti-vaccine Health Secretary Robert F. Kennedy Jr. ACOG President Camille Clare blamed "changing natio...
For the first time, the American College of Obstetricians & Gynecologists (ACOG) has released its own recommendations for maternal vaccination , providing formal guidance that diverges from that of the Centers for Disease Control and Prevention amid unprecedented policy changes and meddling from anti-vaccine Health Secretary Robert F. Kennedy Jr. ACOG President Camille Clare blamed "changing national recommendations coupled with rampant vaccine misinformation" for the confusion among patients and health care professionals about vaccines during pregnancy. "It is incredibly important for the public to have access to reliable, evidence-based information on maternal immunizations from a trusted source. ACOG is proud to be that source," Clare said in a statement . Read full article Comments
Package allocates $38bn to ICE, $26bn to Customs and Border Protection and $5bn more to the DHS Sign up for the Breaking News US newsletter email Donald Trump signed a nearly $70bn immigration enforcement package into law on Wednesday after the House narrowly passed the legislation, ensuring funding for Immigration and Customs Enforcement (ICE) and border patrol activities through the rest of Trum...
Package allocates $38bn to ICE, $26bn to Customs and Border Protection and $5bn more to the DHS Sign up for the Breaking News US newsletter email Donald Trump signed a nearly $70bn immigration enforcement package into law on Wednesday after the House narrowly passed the legislation, ensuring funding for Immigration and Customs Enforcement (ICE) and border patrol activities through the rest of Trump’s presidency. The Secure America Act passed in a 214-212 vote that was largely along party lines, with Kevin Kiley, an independent who aligns with the Republicans, joining all Democrats in voting no. The Senate approved the measure last week, which allocates $38bn to ICE, $26bn to Customs and Border Protection (CBP) and $5bn more to the Department of Homeland Security (DHS) through September 2029. Continue reading...
shih-wei/iStock via Getty Images Investment Thesis Cerebras Systems Inc. ( CBRS) has emerged as one of the most followed AI infrastructure stocks thanks to its $5.55 billion IPO completed in May 2026. Although the stock has retreated somewhat from its highs after the IPO on valuation worries and a pending lockup expiration, the bull case is underpinned by its outstanding $24.6 billion backlog, whi...
shih-wei/iStock via Getty Images Investment Thesis Cerebras Systems Inc. ( CBRS) has emerged as one of the most followed AI infrastructure stocks thanks to its $5.55 billion IPO completed in May 2026. Although the stock has retreated somewhat from its highs after the IPO on valuation worries and a pending lockup expiration, the bull case is underpinned by its outstanding $24.6 billion backlog, which translates into an incredible 48x revenue multiple at FY25 sales of $510 millon, based on large-scale commitments from OpenAI and AWS. The backlog offers unprecedented multi-year visibility into growing revenues while generating strong margins supporting the buy rating. High Topline Visibility Through the $24.6 Billion Backlog and Strategic Cloud-Shift In my view, the main bullish fundamental of Cerebras Systems is its large $24.6 billion backlog. It is supported by a vital $20 billion three year deal with OpenAI ( OPENAI ) and a partnership with Amazon.com, Inc. ( AMZN ) Web Services (AWS). For Cerebras, that had a FY25 topline of $510 million , a backlog of this size is a plinth of multi-year hyper-growth that increases Cerebras’s profile from a hardware vendor to a mission-critical infra partner. The backlog-to-revenue ratio is solid. At $24.6 billion, the backlog is ~48x Cerebras’s FY25 topline. Even if I am applying the conservative 15% recognition rate for the next two years, Cerebras may recognize ~$3.7 billion in topline through FY27. This topline growth may reach and may exceed analyst Jeff Pu’s estimates of $1.2 billion for FY26 and $3.2 billion for FY27. This topline boost provides a floor for forward valuation models on Cerebras stock. SEC S-1/A Further, the move toward a take-or-pay commitment for 750 MW of capacity (with an option for an additional 1.25 GW) indicates that Cerebras is moving its business model toward cloud services. In my fundamental view, this reduces the lumpiness of semiconductor hardware cycles. By securing $1 billion in working capital ...
Sarah Wynn-Williams remained silent during her hour-long appearance, but sales of Careless People have since increased by more than 300% Sales of the whistleblowing memoir Careless People increased by more than 300% in the UK the week after its author was “silenced” during an appearance at Hay festival following legal action by Meta, the subject of the book. Sarah Wynn-Williams – who between 2011 ...
Sarah Wynn-Williams remained silent during her hour-long appearance, but sales of Careless People have since increased by more than 300% Sales of the whistleblowing memoir Careless People increased by more than 300% in the UK the week after its author was “silenced” during an appearance at Hay festival following legal action by Meta, the subject of the book. Sarah Wynn-Williams – who between 2011 and 2017 served as the director of global public policy at what was then called Facebook – sat on stage but did not speak during her hour-long appearance on 31 May on the advice of her lawyer. She appeared alongside the journalist Carole Cadwalladr and academic Tim Wu. Continue reading...
J Studios/DigitalVision via Getty Images Introduction Donegal Group ( DGICA ), for me, looks like an insurance company that has a clear value recovery edge, but if the combined ratio remains at such a level, I don't see a buying opportunity. Donegal Group Inc. is a regional property and casualty insurance holding company whose business model currently has a clear shift towards prioritizing technic...
J Studios/DigitalVision via Getty Images Introduction Donegal Group ( DGICA ), for me, looks like an insurance company that has a clear value recovery edge, but if the combined ratio remains at such a level, I don't see a buying opportunity. Donegal Group Inc. is a regional property and casualty insurance holding company whose business model currently has a clear shift towards prioritizing technical profitability by sacrificing overall revenue growth. Even though in 2025 the company had a record-level net income of $79.3 million and reached a solid ROE of 13.4%, 2026 Q1 results showed increasing pressure: net income dropped 54.3% to $11.5 million, and the combined ratio worsened to 99.8%, compared to 91.6% a year ago. This ratio suggests that insurance activity is on the verge of being negative, mostly due to the rise in compensation costs and the unfavorable weather conditions effect. The company is aggressively decreasing its loss-making personal insurance portfolio, which in Q1 shrank to 13.1%, and is focusing on commercial lines, though this resulted in a decrease in net premiums earned by 4.9% to $221.4 million. Looking at the price-to-book ratio, which is reaching 0.97x, the stock is traded close to its book value, and the P/E ratio of 9.7x reflects that the market is cautious due to the lack of sustainability in profit growth. Dividend yield, after the announced payment increase this year, is reaching 4.5%. Business overview Donegal Group Inc. operates as a regional property and casualty insurance holding company, and currently, its business is in 21 different states. The company's business model is based on insurance servicing through an independent agent network, and the main stream of revenue is the net premiums earned, which in 2026 Q1 reached $221.4 million, showing a 4.9% drop compared to last year. This decrease is directly linked to the strategic product shift: the company is consciously drawing back from the loss-making personal lines segment, where ...
U.S. tech giants have backed a German company in its latest fundraising round to develop its humanoid robotics tech. Neura Robotics' Series C financing, which is worth up to $1.4 billion, featured Tether, Qualcomm, Amazon and Nvidia, alongside European industrial companies Bosch and Schaeffler and the European Investment Bank. The company hit a valuation of around $7 billion, according to a source...
U.S. tech giants have backed a German company in its latest fundraising round to develop its humanoid robotics tech. Neura Robotics' Series C financing, which is worth up to $1.4 billion, featured Tether, Qualcomm, Amazon and Nvidia, alongside European industrial companies Bosch and Schaeffler and the European Investment Bank. The company hit a valuation of around $7 billion, according to a source familiar with the matter, who asked to remain anonymous as they weren't authorized to discuss the information. The company declined to comment on the valuation. "The future of AI will not only live on screens," said David Reger, founder and CEO of Neura Robotics, in a statement. "It will move, interact, learn and work beside us in the real world." The full funding is contingent on Neura hitting certain milestones based on company performance, the source added. Neura declined to comment on the milestones. Investors have piled into robotics startups in recent times as attention turns to deploying AI in physical systems that can interact in real-world environments. Robotics companies have raised $55.8 billion so far in 2026, according to Dealroom, a record figure nearly double the previous record raised last year. The majority of that has been raised by companies in the U.S. and China, but new robotics companies in Europe are also being developed. They include German-based SoftBank-backed Agile Robots and U.K.-based Humanoid. "Many believed globally relevant AI infrastructure companies could only emerge from Silicon Valley," Reger said. "We believe the next generation of AI leaders can emerge anywhere in the world where there is enough vision, engineering talent and execution speed," he added. "With this financing, Neura is firmly among the global leaders in the robotics race, alongside the best in the US and China." Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) and Vanguard Small-Cap Value ETF (NYSEMKT:VBR) both provide low-cost exposure to small-cap value stocks, but they differ in scale, recent performance, and internal sector weightings. Small-cap value stocks often appeal to investors seeking companies with low valuations relative to their fundamentals. While larger growth stocks frequently d...
The iShares Morningstar Small-Cap Value ETF (NYSEMKT:ISCV) and Vanguard Small-Cap Value ETF (NYSEMKT:VBR) both provide low-cost exposure to small-cap value stocks, but they differ in scale, recent performance, and internal sector weightings. Small-cap value stocks often appeal to investors seeking companies with low valuations relative to their fundamentals. While larger growth stocks frequently dominate headlines, these smaller value plays may offer distinct diversification benefits. This comparison looks at how the iShares and Vanguard offerings navigate this volatile but potentially rewarding market segment. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading
Alex Kelly, global co-chair of the M&A and Private Equity Practice at Latham & Watkins, joins Dani Burger on "Bloomberg Deals." They speak at the SuperReturn conference in Berlin. (Source: Bloomberg)
Alex Kelly, global co-chair of the M&A and Private Equity Practice at Latham & Watkins, joins Dani Burger on "Bloomberg Deals." They speak at the SuperReturn conference in Berlin. (Source: Bloomberg)
Anthropic released Claude Fable , its first Mythos-class AI model, yesterday and it's already causing concerns inside Microsoft. Sources tell me that Microsoft is limiting the use of Claude Fable 5 for employees because of Anthropic's new data retention requirements. While Microsoft quickly rolled out Claude Fable 5 to its GitHub Copilot and Foundry customers, I'm told the model isn't available in...
Anthropic released Claude Fable , its first Mythos-class AI model, yesterday and it's already causing concerns inside Microsoft. Sources tell me that Microsoft is limiting the use of Claude Fable 5 for employees because of Anthropic's new data retention requirements. While Microsoft quickly rolled out Claude Fable 5 to its GitHub Copilot and Foundry customers, I'm told the model isn't available in the model picker that Microsoft employees use for internal versions of GitHub Copilot. All other Claude models are still available internally at Microsoft, because they operate under Zero Data Retention (ZDR) rules. I understand that Microsoft ha … Read the full story at The Verge.
Oselote/iStock via Getty Images The market reaction to Broadcom's ( AVGO ) latest results says more about investor positioning than anything else. The company is reporting record revenues, record operating margins, record AI revenues, record bookings, and providing much more optimistic guidance for the coming quarter. Despite all that, the stock got hammered due to expectations detaching from real...
Oselote/iStock via Getty Images The market reaction to Broadcom's ( AVGO ) latest results says more about investor positioning than anything else. The company is reporting record revenues, record operating margins, record AI revenues, record bookings, and providing much more optimistic guidance for the coming quarter. Despite all that, the stock got hammered due to expectations detaching from reality again. While the decline itself is not particularly interesting, what caught my attention was that Broadcom is likely turning into a key AI infrastructure player from being a beneficiary of the wave. There is a difference between the two. Beneficiaries tend to go through growth waves while infrastructures are often built during their lifetimes. After analyzing the latest earnings call and recent developments, I think that the market is still considering Broadcom a chipmaker while it should see it becoming the coordinator of frontier compute deployments. The Business Is Performing Far Better Than The Narrative Assumes The primary talking point after earnings is why the company chose not to raise its 2027 AI revenue targets above $100 billion and decided to provide $16 billion in guidance for the next quarter compared to whisper numbers that were circulating in the market. While I have a hard time understanding why investors were expecting something different, the numbers provided by Broadcom look really good. First of all, AI semiconductor revenues in Q2 amounted to $10.8 billion and grew 143% yoy. However, what really caught my attention was the bookings level, which was above $30 billion compared to $10.8 billion of shipped revenues. This ratio suggests that the market is not just absorbing all the supplies but is making plans years ahead. The second signal worth focusing on is the customer base, which is increasingly dominated by Google, Anthropic, OpenAI, Meta, and two other undisclosed parties that are not experimental anymore. Broadcom is selling multiple types of ...